Literature DB >> 19521117

Fatigue in cancer survivors--prevalence and correlates.

Susanne Kuhnt1, Jochen Ernst, Susanne Singer, Jens Ulrich Rüffer, Rolf-Dieter Kortmann, Jens-Uwe Stolzenburg, Reinhold Schwarz.   

Abstract

BACKGROUND: The aim of this study was to determine the prevalence and influencing factors of fatigue in cancer survivors. PATIENTS AND METHODS: 646 cancer survivors completed the Multidimensional Fatigue Inventory (MFI-20), in addition to the Hospital Anxiety and Depression Scale (HADS), the Quality Of Life questionnaire EORTC QLQ-C30 (European Organization for Research and Treatment of Cancer QLQ-C30), the subscale 'social support' of the Functional Assessment of Cancer Therapy Scale (FACT), the Perceived Adjustment to Chronic Illness Scale (PACIS), and a questionnaire containing items on demographic and clinical data.
RESULTS: 36% of cancer survivors suffer from moderate, 12% from severe fatigue. Fatigue was significantly associated with depression, anxiety, sleep difficulties, adjustment to the illness, pain, dyspnoea, age, lacking social support, and sex. Other socio-demographic, cancer-related, and treatment-related factors had no influence on fatigue.
CONCLUSION: Fatigue in cancer survivors is strongly linked to physical and psychological aspects. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19521117     DOI: 10.1159/000215943

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  27 in total

1.  Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors.

Authors:  Qiuling Shi; Tenbroeck G Smith; Jared D Michonski; Kevin D Stein; Chiewkwei Kaw; Charles S Cleeland
Journal:  Cancer       Date:  2011-04-14       Impact factor: 6.860

2.  A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands.

Authors:  Simone Oerlemans; Floortje Mols; Djamila E Issa; J H F M Pruijt; Wim G Peters; Marnix Lybeert; Wobbe Zijlstra; Jan Willem W Coebergh; Lonneke V van de Poll-Franse
Journal:  Haematologica       Date:  2012-08-28       Impact factor: 9.941

3.  Physical Activity and Fatigue in Patients with Sarcoidosis.

Authors:  Thomas Bahmer; Henrik Watz; Maria Develaska; Benjamin Waschki; Klaus F Rabe; Helgo Magnussen; Detlef Kirsten; Anne-Marie Kirsten
Journal:  Respiration       Date:  2017-11-09       Impact factor: 3.580

4.  Health status, use of healthcare, and socio-economic implications of cancer survivorship in Portugal: results from the Fourth National Health Survey.

Authors:  Luís Pacheco-Figueiredo; Nuno Lunet
Journal:  J Cancer Surviv       Date:  2014-06-06       Impact factor: 4.442

5.  Validation of the Chinese version of Multidimensional Fatigue Inventory-20 in Chinese patients with cancer.

Authors:  Jun Tian; Jin-Sheng Hong
Journal:  Support Care Cancer       Date:  2011-12-24       Impact factor: 3.603

Review 6.  Cancer-related fatigue in the elderly.

Authors:  A Giacalone; D Quitadamo; E Zanet; M Berretta; M Spina; U Tirelli
Journal:  Support Care Cancer       Date:  2013-07-13       Impact factor: 3.603

7.  Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma.

Authors:  Aylin Mehren; Jale Özyurt; Paula Zu Klampen; Svenja Boekhoff; Christiane M Thiel; Hermann L Müller
Journal:  J Neurooncol       Date:  2018-07-03       Impact factor: 4.130

8.  Cancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatment.

Authors:  Markus Horneber; Irene Fischer; Fernando Dimeo; Jens Ulrich Rüffer; Joachim Weis
Journal:  Dtsch Arztebl Int       Date:  2012-03-02       Impact factor: 5.594

9.  Fatigue in the general population: German normative values of the EORTC QLQ-FA12.

Authors:  Andreas Hinz; Joachim Weis; Elmar Brähler; Anja Mehnert
Journal:  Qual Life Res       Date:  2018-06-16       Impact factor: 4.147

Review 10.  Yoga for the Management of Cancer Treatment-Related Toxicities.

Authors:  Po-Ju Lin; Luke J Peppone; Michelle C Janelsins; Supriya G Mohile; Charles S Kamen; Ian R Kleckner; Chunkit Fung; Matthew Asare; Calvin L Cole; Eva Culakova; Karen M Mustian
Journal:  Curr Oncol Rep       Date:  2018-02-01       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.